Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14883495
[patent_doc_number] => 10421774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/071925
[patent_app_country] => US
[patent_app_date] => 2017-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44368
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071925
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071925 | C-3 and C-17 modified triterpenoids as HIV-1 inhibitors | Feb 1, 2017 | Issued |
Array
(
[id] => 13870649
[patent_doc_number] => 20190031665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => DERIVATIVES OF PYRROLOIMIDAZOLE OR ANALOGUES THEREOF WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA CANCER
[patent_app_type] => utility
[patent_app_number] => 16/071712
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 473
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071712 | DERIVATIVES OF PYRROLOIMIDAZOLE OR ANALOGUES THEREOF WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA CANCER | Jan 30, 2017 | Abandoned |
Array
(
[id] => 13065337
[patent_doc_number] => 10053441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Methods for purifying 5-(halomethyl)furfural
[patent_app_type] => utility
[patent_app_number] => 15/418385
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8867
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15418385
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/418385 | Methods for purifying 5-(halomethyl)furfural | Jan 26, 2017 | Issued |
Array
(
[id] => 13901745
[patent_doc_number] => 20190040077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => TRIAZOLE DERIVATIVES OF MELAMPOMAGNOLIDE B AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/073705
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073705
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073705 | Triazole derivatives of melampomagnolide B and methods of use thereof | Jan 26, 2017 | Issued |
Array
(
[id] => 12562638
[patent_doc_number] => 10016448
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
[patent_app_type] => utility
[patent_app_number] => 15/417953
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 33237
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 467
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417953
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417953 | Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity | Jan 26, 2017 | Issued |
Array
(
[id] => 11757207
[patent_doc_number] => 20170204075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'AMINOALCOHOL LIPIDOIDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/417530
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 34024
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417530
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417530 | Aminoalcohol lipidoids and uses thereof | Jan 26, 2017 | Issued |
Array
(
[id] => 13901763
[patent_doc_number] => 20190040086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => Preparation Of Ammonium or Phosphonium Borate Salts
[patent_app_type] => utility
[patent_app_number] => 16/075547
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075547 | Preparation of ammonium or phosphonium borate salts | Jan 26, 2017 | Issued |
Array
(
[id] => 12509007
[patent_doc_number] => 10000452
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-06-19
[patent_title] => Quinolone-based compounds, formulations, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/412667
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 26
[patent_no_of_words] => 42697
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15412667
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/412667 | Quinolone-based compounds, formulations, and uses thereof | Jan 22, 2017 | Issued |
Array
(
[id] => 14793949
[patent_doc_number] => 10399966
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Compounds for treatment of trypanosomes and neurological pathogens and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/071048
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 24360
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071048
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071048 | Compounds for treatment of trypanosomes and neurological pathogens and uses thereof | Jan 19, 2017 | Issued |
Array
(
[id] => 11619666
[patent_doc_number] => 20170129853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'Carbondisulfide Derived Zwitterions'
[patent_app_type] => utility
[patent_app_number] => 15/410486
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 4416
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15410486
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/410486 | Carbondisulfide derived zwitterions | Jan 18, 2017 | Issued |
Array
(
[id] => 12254167
[patent_doc_number] => 09926302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Heteroaryl substituted heterocyclyl sulfones'
[patent_app_type] => utility
[patent_app_number] => 15/404758
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93302
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15404758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/404758 | Heteroaryl substituted heterocyclyl sulfones | Jan 11, 2017 | Issued |
Array
(
[id] => 13687391
[patent_doc_number] => 20170354650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => QUINOLINE DERIVATIVES FOR INHIBITING HISTONE METHYLTRANSFERASES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/403404
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15403404
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/403404 | Quinoline derivatives for inhibiting histone methyltransferases and use thereof | Jan 10, 2017 | Issued |
Array
(
[id] => 11956011
[patent_doc_number] => 20170260162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'POLYMORPHIC FORMS OF NILOTINIB HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 15/402890
[patent_app_country] => US
[patent_app_date] => 2017-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7843
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15402890
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/402890 | Polymorphic forms of nilotinib hydrochloride | Jan 9, 2017 | Issued |
Array
(
[id] => 12499296
[patent_doc_number] => 09997727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Organic electroluminescent materials and devices
[patent_app_type] => utility
[patent_app_number] => 15/401438
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11718
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15401438
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/401438 | Organic electroluminescent materials and devices | Jan 8, 2017 | Issued |
Array
(
[id] => 11589648
[patent_doc_number] => 20170114059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/401839
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35505
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15401839
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/401839 | Macrocyclic compounds as Trk kinase inhibitors | Jan 8, 2017 | Issued |
Array
(
[id] => 11743846
[patent_doc_number] => 20170197916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'FUNCTIONALIZED PEGYLATED CYANINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/400892
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42299
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400892
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/400892 | Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof | Jan 5, 2017 | Issued |
Array
(
[id] => 14924509
[patent_doc_number] => 20190297892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => MICROBIOCIDAL OXADIAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/068638
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 1357
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068638 | Microbiocidal oxadiazole derivatives | Jan 4, 2017 | Issued |
Array
(
[id] => 11619677
[patent_doc_number] => 20170129865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'STEREO CONTROLLED SYNTHESIS OF (E,Z)-DIENALS VIA TANDEM RH(I) CATALYZED PROPARGYL CLAISEN REARRANGEMENT'
[patent_app_type] => utility
[patent_app_number] => 15/398094
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12013
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398094
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398094 | Stereo controlled synthesis of (E,Z)-dienals via tandem Rh(I) catalyzed propargyl claisen rearrangement | Jan 3, 2017 | Issued |
Array
(
[id] => 12448242
[patent_doc_number] => 09981932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Bioderived based plasticizers
[patent_app_type] => utility
[patent_app_number] => 15/396755
[patent_app_country] => US
[patent_app_date] => 2017-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2589
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15396755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/396755 | Bioderived based plasticizers | Jan 1, 2017 | Issued |
Array
(
[id] => 11729218
[patent_doc_number] => 20170190661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'Aromatic Ionizable Cationic Lipid'
[patent_app_type] => utility
[patent_app_number] => 15/393840
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23420
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15393840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/393840 | Aromatic ionizable cationic lipid | Dec 28, 2016 | Issued |